Subjective urinary symptoms
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Blood pressure · people with diabetes and orthostatic hypotension
1 finding from 1 review
no estimate extracted
1 study · 6 participants
Very low
Orthostatic symptoms · people with diabetes and orthostatic hypotension
1 finding from 1 review
no estimate extracted
1 study · 6 participants
Very low
Frequency and severity of postural lightheadedness · people with diabetes and orthostatic hypotension
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Frequency of syncope · people with diabetes and orthostatic hypotension
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Quality of life · people with diabetes and orthostatic hypotension
1 finding from 1 review
no estimate extracted
0 participants
GRADE not reported
Serious or severe adverse events · people with diabetes and orthostatic hypotension
1 finding from 1 review
no estimate extracted
1 study · 6 participants
Very low
Relief of pain · primary dysmenorrhoea
It is very uncertain whether nifedipine changes pain relief (any) compared with placebo (very low certainty).
1 finding from 1 review
Good or excellent pain relief · primary dysmenorrhoea
It is very uncertain whether nifedipine changes good or excellent pain relief compared with placebo (very low certainty).
1 finding from 1 review
Health‐related quality of life · primary dysmenorrhoea
The review found no eligible studies for this question.
1 finding from 1 review
Total adverse effects · primary dysmenorrhoea
It is very uncertain whether nifedipine changes total adverse effects compared with placebo (very low certainty).
1 finding from 1 review
Bothersome adverse effects · primary dysmenorrhoea
It is very uncertain whether nifedipine changes bothersome adverse effects compared with placebo (very low certainty).
1 finding from 1 review
Requirement for additional medication · primary dysmenorrhoea
It is very uncertain whether nifedipine changes requirement for additional medication compared with placebo (very low certainty).
1 finding from 1 review
Death (any cause) · patients with diarrhoea due to Shiga toxin‐producing E. coli
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of HUS · patients with diarrhoea due to Shiga toxin‐producing E. coli
It is very uncertain whether synsorb Pk changes incidence of HUS compared with placebo (very low certainty).
1 finding from 1 review
Adverse events · patients with diarrhoea due to Shiga toxin‐producing E. coli
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Need for acute dialysis · patients with diarrhoea due to Shiga toxin‐producing E. coli
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Neurological complications · patients with diarrhoea due to Shiga toxin‐producing E. coli
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Death (any cause) · patients with diarrhoea due to Shiga toxin‐producing E. coli
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Incidence of HUS · paediatric patients with diarrhoea due to Shiga toxin‐producing E. coli
It is very uncertain whether urtoxazumab (3.0 mg/kg) changes incidence of HUS compared with placebo (very low certainty).
1 finding from 1 review